HUMAN GENOME SCIENCES INC Capital Expenditures
HUMAN GENOME SCIENCES INC reported Capital Expenditures of $5.25 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-07-26.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2012-07-26
- HUMAN GENOME SCIENCES INC payments to acquire property, plant, and equipment for the quarter ending 2012-06-30 was $3.04M, a 40.24% decline year-over-year.
- HUMAN GENOME SCIENCES INC payments to acquire property, plant, and equipment for the quarter ending 2012-03-31 was $2.21M, a 8.08% decline year-over-year.
- HUMAN GENOME SCIENCES INC payments to acquire property, plant, and equipment for the quarter ending 2011-12-31 was $7.50M, a 116.40% increase year-over-year.
- HUMAN GENOME SCIENCES INC payments to acquire property, plant, and equipment for the quarter ending 2011-09-30 was $4.01M, a 102.42% increase year-over-year.
- HUMAN GENOME SCIENCES INC payments to acquire property, plant, and equipment for fiscal 2011 was $18.99M, a 94.12% increase from fiscal 2010.
- HUMAN GENOME SCIENCES INC payments to acquire property, plant, and equipment for fiscal 2010 was $9.78M, a 2.37% decline from fiscal 2009.
- HUMAN GENOME SCIENCES INC payments to acquire property, plant, and equipment for fiscal 2009 was $10.02M.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2012-06-30 | $3.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | $5.25M 10-Q · filed 2012-07-26 | $12.74M derived: sum of 3 quarters · filed 2012-07-26 | $16.75M derived: sum of 4 quarters · filed 2012-07-26 |
| 2012-03-31 | $2.21M 10-Q · filed 2012-04-26 | $9.70M derived: sum of 2 quarters · filed 2012-04-26 | $13.71M derived: sum of 3 quarters · filed 2012-04-26 | $18.80M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-12-31 | $7.50M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $11.50M derived: sum of 2 quarters · filed 2012-02-28 | $16.59M derived: sum of 3 quarters · filed 2012-07-26 | $18.99M 10-K · filed 2012-02-28 |
| 2011-09-30 | $4.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $9.09M derived: sum of 2 quarters · filed 2012-07-26 | $11.49M 10-Q · filed 2011-10-28 | $14.96M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-06-30 | $5.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | $7.49M 10-Q · filed 2012-07-26 | $10.95M derived: sum of 3 quarters · filed 2012-07-26 | $12.93M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-03-31 | $2.40M 10-Q · filed 2012-04-26 | $5.86M derived: sum of 2 quarters · filed 2012-04-26 | $7.84M derived: sum of 3 quarters · filed 2012-04-26 | $10.40M derived: sum of 4 quarters · filed 2012-04-26 |
| 2010-12-31 | $3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $5.44M derived: sum of 2 quarters · filed 2012-02-28 | $8.00M derived: sum of 3 quarters · filed 2012-02-28 | $9.78M 10-K · filed 2012-02-28 |
| 2010-09-30 | $1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $4.54M derived: sum of 2 quarters · filed 2011-10-28 | $6.32M 10-Q · filed 2011-10-28 | |
| 2010-06-30 | $2.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $4.34M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $1.78M 10-Q · filed 2011-04-29 | |||
| 2009-12-31 | $10.02M 10-K · filed 2012-02-28 |